Cart
sales@molnova.com
Home - Products - TGF-beta/Smad - TGFBR - IN-1233 phosphate

IN-1233 phosphate

CAS No. 1093953-38-8

IN-1233 phosphate( IN1233 | IN 1233 )

Catalog No. M10362 CAS No. 1093953-38-8

A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    IN-1233 phosphate
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM.
  • Description
    A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    IN1233 | IN 1233
  • Pathway
    TGF-beta/Smad
  • Target
    TGFBR
  • Recptor
    TGFBR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1093953-38-8
  • Formula Weight
    517.482
  • Molecular Formula
    C26H24N5O5P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    3-((4-(6-methylpyridin-2-yl)-5-(quinolin-6-yl)-1H-imidazol-2-yl)methyl)benzamide phosphate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kim JH, et al. Radiology, May 2013 Volume 267, Issue 2, doi.org/10.1148/radiol.121203612. Kim JH, et al. Radiology. 2010 Apr;255(1):75-82.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • SRI-011381 hydrochlo...

    SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.

  • Protein Kinase C 19-...

    Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.

  • JL5

    JL5 is a novel potent, selective BMP receptor inhibitor with IC50 of 1, <5 and 2 nM for ALK2/ACVR1, ALK3/BMPR1A and ALK6/BMPR1B, respectively.

Sign In Join Free